Chaoxin Hu

Author PubWeight™ 11.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interaction of imatinib with human organic ion carriers. Clin Cancer Res 2008 1.47
2 Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase. Clin Cancer Res 2010 1.01
3 Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain. Mol Cancer Ther 2007 1.00
4 Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer 2013 0.99
5 MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res 2013 0.93
6 A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. Mol Cancer Ther 2011 0.91
7 Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 2011 0.90
8 Cisplatin-induced downregulation of OCTN2 affects carnitine wasting. Clin Cancer Res 2010 0.87
9 Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 2014 0.85
10 A novel polypeptide from shark cartilage with potent anti-angiogenic activity. Cancer Biol Ther 2007 0.85
11 Targeting cellular proapoptotic molecules for developing anticancer agents from marine sources. Curr Drug Targets 2010 0.84
12 Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agents. J Environ Sci Health A Tox Hazard Subst Environ Eng 2014 0.77